Article

Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against Omicron

2022-04-15

Abstract excerpt

Omicron (B.1.1.529) shows extensive escape from vaccine immunity, although vaccination reduces severe disease and death 1 . Boosting with vaccines incorporating variant spike sequences could possibly broaden immunity 2 . One approach to choose the variant may be to measure immunity elicited by vaccination combined with variant infection. Here we investigated Omicron neutralization in people infected with the Beta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cdba4335-fad9-500b-944f-eb1ac9e10b42
DOI: 10.1101/2022.04.15.22273711

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against OmicronDOI 10.1101/2022.04.15.22273711Read

Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2Semantic proximity Read

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemicSemantic proximity Read

Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccineSemantic proximity Read

Three doses of the BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 B.1.1.529 (Omicron) variant of concernSemantic proximity Read

Post-vaccination neutralization responses to Omicron sub-variantsSemantic proximity Read

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.Semantic proximity Read

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between dosesSemantic proximity Read

Neutralization of SARS-CoV-2 Omicron pseudovirus by BNT162b2 vaccine-elicited human seraSemantic proximity Read

Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-monthsSemantic proximity Read

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infectionSemantic proximity Read

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other VariantsSemantic proximity Read

Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes OmicronSemantic proximity Read